Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             305 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABC’s of ABO-A refresher for blood and marrow transplant nurses Meyers, A.L.
 2004
 10 S1 p. 95-
1 p.
 artikel
2 ABO blood group antibodies after allogeneic hematopoietic stem cell transplantation Stussi, G.
 2004
 10 S1 p. 55-
1 p.
 artikel
3 Abrogation of the interactions between cxcr3 and its ligands MIG and IP-10 reduces the severity of idiopathic pneumonia syndrome after allogeneic stem cell transplantation Hildebrandt, G.C.
 2004
 10 S1 p. 17-18
2 p.
 artikel
4 Absence of inducible costimulator on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact Tjoe, K.H.
 2004
 10 S1 p. 50-51
2 p.
 artikel
5 Accelerated immune reconstitution using LLME treated donor lymphocyte infusions Filicko, J.E.
 2004
 10 S1 p. 22-23
2 p.
 artikel
6 A combinational method to identify HLA-DRB1∗0401 individuals for immunotherapeutic studies Huang, X.
 2004
 10 S1 p. 56-57
2 p.
 artikel
7 Activated allogeneic NK cells as suppressors of host alloreactive responses Liu, H.
 2004
 10 S1 p. 39-
1 p.
 artikel
8 A decade of myeloablative hla-matched sibling marrow transplantation for children with severe sickle cell disease: outcomes and lessons learned from the Atlanta experience Haight, A.E.
 2004
 10 S1 p. 29-
1 p.
 artikel
9 Adoptive transfer of ex vivo costimulated autologous T-cells after autotransplantation for myeloma (MM)accelerates post-transplant T-cell recovery Rapoport, A.P.
 2004
 10 S1 p. 22-
1 p.
 artikel
10 Adoptive transfer of primed T cells prior to ablative conditioning and BMT results in syngeneic anti-tumor immunity early post-transplant Jones, M.
 2004
 10 S1 p. 51-
1 p.
 artikel
11 A high throughput SNP based KIR genotyping system for use in allogeneic transplantation and outcomes analyses Houtchens, K.A.
 2004
 10 S1 p. 33-34
2 p.
 artikel
12 Aldehyde dehydrogenase [ALDH] and surface antigen expression define hematopoeitic stem and progenitor cell [HSPC] subsets differentially represented in mobilized peripheral blood [PBSC], umbilical cord blood [UCB], and bone marrow [BM] Gentry, T.
 2004
 10 S1 p. 30-
1 p.
 artikel
13 Allogeneic blood and marrow transplantation in thalassemia major class 3: an experience of Iran Ghavamzadeh, A.
 2004
 10 S1 p. 77-
1 p.
 artikel
14 Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1) Boulad, F.
 2004
 10 S1 p. 26-
1 p.
 artikel
15 Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: results of a prospective, multicenter study Ruiz-Arguelles, G.J.
 2004
 10 S1 p. 32-
1 p.
 artikel
16 Allogeneic hsct with reduced intensity conditioning regimens in high risk patients with myelofibrosis Rondelli, D.
 2004
 10 S1 p. 12-
1 p.
 artikel
17 Allogeneic memory response contributes to the persistence of allorective T cells for mediating graft-versus-host disease Zhang, Y.
 2004
 10 S1 p. 54-
1 p.
 artikel
18 Allogeneic stem cell transplantation for the treatment of 12 patients with paroxysmal nocturnal hemoglobinuria in Brazil Bonfim, C.M.S.
 2004
 10 S1 p. 42-
1 p.
 artikel
19 Allogeneic stem cell transplantation (SCT) for patients (pts) with thalassemia major: an inferior outcome when antithymocyte globlins (ATG) is added to the conditioning regimen Al-Jefri, A.
 2004
 10 S1 p. 9-
1 p.
 artikel
20 Allogeneic stem-cell transplantation with matched unrelated donors in elderly patients (55–67 years); age by itself is no longer a contraindication Shimoni, A.
 2004
 10 S1 p. 56-
1 p.
 artikel
21 Allogeneic transplantation for mantle cell lymphoma Bence-Bruckler, I.A.
 2004
 10 S1 p. 10-
1 p.
 artikel
22 A long term follow up study of autologous transplantation for follicular lymphoma: a single center experience Ganguly, S.
 2004
 10 S1 p. 63-
1 p.
 artikel
23 Altered CD34 expression of umbilical cord blood after thawing Shaw, P.H.
 2004
 10 S1 p. 81-
1 p.
 artikel
24 AML patients lacking kir ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants Hsu, K.C.
 2004
 10 S1 p. 7-
1 p.
 artikel
25 AML transplantation: autologous vs allogeneic Ghavamzadeh, A.
 2004
 10 S1 p. 60-61
2 p.
 artikel
26 A multi-institutional study of extracorporeal photophoresis (ECP) with Uvadex® for the prevention of acute graft vs. host disease (aGvHD) in patients (pts) undergoing allogeneic hematopoietic progenitor cell transplants (allo-HPCT) with myeloablative conditioning Abhyankar, S.
 2004
 10 S1 p. 53-
1 p.
 artikel
27 Analysis of disease behavior of patients with hematopoietic stem cell transplantation and nursing care Su, R.
 2004
 10 S1 p. 93-
1 p.
 artikel
28 An efficacy of interferon-α (IFN-α) and interleukin-2 (IL-2) in the treatment of hematological malignancies relapse-persistence-progression after the allogeneic nonmyeloablative stem cell transplantation (NSCT) Raida, L.
 2004
 10 S1 p. 48-
1 p.
 artikel
29 An emerging challenge: nursing skin care of bone marrow transplant patients with mycosis fungoides Huynh, C.D.
 2004
 10 S1 p. 98-
1 p.
 artikel
30 An investigational study on telephone calls by period post stem cell transplantation Kim, K.S.
 2004
 10 S1 p. 96-
1 p.
 artikel
31 A non-viral method of transfecting MRNA from a neuroblastoma (NBL) cell line (NGP) into immature dendritic cells (DC) Stephan, B.S.
 2004
 10 S1 p. 81-
1 p.
 artikel
32 A novel approach for ex-vivo expansion (EvE) of NK CD3−/CD16+/56+bright/dim subsets expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved/rethawed (CTECT) and cryopreserved/thawed/recryopreserved/rethawed/expanded (CTCTE) umbilical cord blood (UCB) using anti-CD3, IL-2, IL-7 and IL-12 (AB/CY) Ayello, J.
 2004
 10 S1 p. 16-
1 p.
 artikel
33 A novel conditioning regimen of immune suppression with campath-1H, fludarabine and melphalan in stem cell transplantation for non-malignant disorders Barnes, Y.
 2004
 10 S1 p. 77-78
2 p.
 artikel
34 Antibody response to H-Y minor histocompatibility antigens correlates with chronic graft versus host disease and disease remission Miklos, D.B.
 2004
 10 S1 p. 18-19
2 p.
 artikel
35 Anti-donor isoagglutinin reduction and pure red cell aplasia after major ABO-incompatible HSCT Stussi, G.
 2004
 10 S1 p. 43-
1 p.
 artikel
36 Anti-3rd party veto CTLs depleted of host reactive clones retain a broad TCR repertoire: a potential new source for adoptive immune therapy in bone marrow transplantation Aviner, S.
 2004
 10 S1 p. 22-
1 p.
 artikel
37 Anti-thymocyte-globulin (ATG) in the nonmyeloablative conditioning for canine hematopoietic cell transplant (HCT) Diaconescu, R.
 2004
 10 S1 p. 43-44
2 p.
 artikel
38 A phase I/II study of xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma Martin, T.
 2004
 10 S1 p. 27-28
2 p.
 artikel
39 A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation Castro-Malaspina, H.
 2004
 10 S1 p. 40-
1 p.
 artikel
40 Apheresis patient satisfaction survey: an ongoing quality improvement process Sorensen, S.H.
 2004
 10 S1 p. 100-
1 p.
 artikel
41 A pilot study of myeloablative (MA) autologous stem cell transplantation (AUTOSCT) followed by reduced intensity (RI) allogeneic transplantation (ALLOSCT) in children and young adults with relapsed/refractory lymphoma Bradley, M.B.
 2004
 10 S1 p. 70-
1 p.
 artikel
42 A pilot test of an APN intervention in HCT patients Cooke, L.D.
 2004
 10 S1 p. 96-
1 p.
 artikel
43 A reference guide to seamless care: the blood and marrow transplant coordinator orientation manual Morse, R.
 2004
 10 S1 p. 98-
1 p.
 artikel
44 A requirement for the spleen in preventing sustained imbalance of B220+ cells and GR-1+ cells during reconstitution following syngeneic and allogeneic BMT Shatry, A.M.
 2004
 10 S1 p. 67-
1 p.
 artikel
45 A retrospective analysis of hospital admissions in an outpatient stem cell transplant facility Malone, C.
 2004
 10 S1 p. 91-
1 p.
 artikel
46 A retrospective comparison of the impact of darbepoetin or epoetin usage on red cell transfusions transfusions in autologous stem cell transplantation (SCT) for light-chain related amyloidosis Baribeault, D.M.
 2004
 10 S1 p. 92-
1 p.
 artikel
47 A review of cytomegalovirus infections following nonmyeloablative allogeneic stem cell transplants using Campath-1H Thompson, M.
 2004
 10 S1 p. 99-
1 p.
 artikel
48 ASCT in a young patient with features of poems syndrome evolving to multiple myeloma Roesler, W.
 2004
 10 S1 p. 70-71
2 p.
 artikel
49 A single centre, randomised trial on harvest cell yield and marrow engraftment using haemopoietic growth-factor primed bone marrow Lu, K.H.
 2004
 10 S1 p. 32-
1 p.
 artikel
50 A support network for patients and families after blood and marrow transplantation Anders, V.L.
 2004
 10 S1 p. 93-94
2 p.
 artikel
51 A test dose of I.V. busulfan (BU) is predictive of the area under the curve (AUC) of a single daily dose of I.V. bu in pediatric patients undergoing a reduced intensity (RI) hematopoietic stem cell transplant (HSCT) Kletzel, M.
 2004
 10 S1 p. 75-76
2 p.
 artikel
52 Author index 2004
 10 S1 p. 108-112
5 p.
 artikel
53 Autologous hematopoietic stem cell transplantation for Takayasu’s arteritis: report of the first case of the literature Voltarelli, J.C.
 2004
 10 S1 p. 62-
1 p.
 artikel
54 Autologous stem cell transplantation for the treatment of pediatric solid tumors in Brazil Castro, C.G.
 2004
 10 S1 p. 78-79
2 p.
 artikel
55 Autologous stem cell transplantation (SCT) in pediatric patients with advanced Hodgkin’s lymphoma (HL): the role of interferon-alpha post-transplant Petropoulos, D.
 2004
 10 S1 p. 79-
1 p.
 artikel
56 Autologous stem cell transplant for multiple myeloma and lymphoma without transfusion support Ford, P.A.
 2004
 10 S1 p. 65-66
2 p.
 artikel
57 Autologous versus allogeneic stem cell transplant for multiple myeloma Arora, M.
 2004
 10 S1 p. 71-72
2 p.
 artikel
58 Beam allogeneic transplant in patients failing autologous transplantation for Hodgkin’s disease offers an opportunity for long-term survival Stilwill, J.F.
 2004
 10 S1 p. 41-
1 p.
 artikel
59 Be impressed with PRES Mishaw, K.
 2004
 10 S1 p. 94-
1 p.
 artikel
60 Bone marrow angiogenesis decreases after stem cell transplantation for treatment of leukemia Shariftabrizi, A.
 2004
 10 S1 p. 60-
1 p.
 artikel
61 Bone marrow transplantation (BMT) for children and adolescents with severe acquired aplastic anemia (SAA): a single center experience in 171 patients (pts) comparing two different preparatory regimens Bonfim, C.M.S.
 2004
 10 S1 p. 29-
1 p.
 artikel
62 Both tissue derived and bone marrow derived stromal cells are immunoregulatory Kleiner, G.I.
 2004
 10 S1 p. 82-
1 p.
 artikel
63 Canadian pilot trial of haplo-identical donor transplantation Walker, I
 2004
 10 S1 p. 38-
1 p.
 artikel
64 Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Gidron, A.
 2004
 10 S1 p. 62-63
2 p.
 artikel
65 Celiac disease transmitted by cord blood stem cell transplantation (CBST) Baothman, A.A.
 2004
 10 S1 p. 77-
1 p.
 artikel
66 Characterization of the tumor-specific activity of WT1 specific T cells generated in vitro from normal individuals by sensitization with WT1-peptide loaded autologous EBV transformed B cells Doubrovina, E.S.
 2004
 10 S1 p. 19-
1 p.
 artikel
67 Chimerism and tolerance post in utero transplantation with ontogenically different sources of stem cells Carrier, E.
 2004
 10 S1 p. 57-
1 p.
 artikel
68 Clinical efficacy of granulocyte transfusion in patients with severe neutropenic infections Kim, J.-S.
 2004
 10 S1 p. 92-
1 p.
 artikel
69 Clinical evaluation of the adverse effects of voriconazole in the management of hemopoeitic stem cell transplant patients Li, H.
 2004
 10 S1 p. 86-87
2 p.
 artikel
70 Clinical research professionals and data manager network - newsletter: www.datamanager.blogspot.com Laursen, H.B
 2004
 10 S1 p. 106-
1 p.
 artikel
71 Clinical role of quantitative viral load monitoring for adenovirus in immunocompromised patients Manna, P.
 2004
 10 S1 p. 88-
1 p.
 artikel
72 Common lymphoid progenitors require common gamma (γc) and C-kit signals for survival in vivo Dudl, E.
 2004
 10 S1 p. 82-83
2 p.
 artikel
73 Co-morbidities aging population on the rise Rivera, Z.R.
 2004
 10 S1 p. 102-
1 p.
 artikel
74 Comparison of lymphoid and myeloid engraftment rates in patients receiving fludarabine/TBI or fludarabine/cyclophosphamide for non-myeloablative allogeneic transplantation Mellon-Reppen, S.
 2004
 10 S1 p. 50-
1 p.
 artikel
75 Comparison of outcomes after transplantation of unrelated donor umbilical cord blood versus matched sibling bone marrow for pediatric patients with leukemia and myelodysplastic syndromes Rodriguez-Marino, S.
 2004
 10 S1 p. 12-
1 p.
 artikel
76 Comparisons of hematopoietic support by adipose-derived and bone marrow-derived stroma Storms, R.W.
 2004
 10 S1 p. 67-68
2 p.
 artikel
77 Continuous platelet drip: a unique approach in the treatment of severe/refractory thrombocytopenia in the pediatric stem cell transplant population Talbert, G.
 2004
 10 S1 p. 101-102
2 p.
 artikel
78 Cord blood natural killer T (NKT) cells Dalle, J.-H.
 2004
 10 S1 p. 57-
1 p.
 artikel
79 Correlation of pre-hematopoietic cell transplant (HCT) pro-inflammatory cytokines in bronchioalveolar lavage (BAL) fluid with pulmonary complications following HCT in patients with inherited metabolic storage disorders (IMSDs) Kharbanda, S.
 2004
 10 S1 p. 35-
1 p.
 artikel
80 CR1 acute myeloid leukemia and HLA-identical allogeneic transplantation (ASCT) prepared with reduced intensity regimen (RIC): leukemia control requires adequate pre graft chemotherapy and post graft GVHD Faucher, C.
 2004
 10 S1 p. 61-
1 p.
 artikel
81 Cross-protective T cell responses to murine myeloid leukemias are revealed by characterization of the CD8+ T cell repertoire Lewandowski, A.M.
 2004
 10 S1 p. 55-
1 p.
 artikel
82 Cryotherapy (ice chips) is effective in preventing melphalan-induced oral mucositis (OM) in patients with AL amyloidosis Finn, K.T.
 2004
 10 S1 p. 86-
1 p.
 artikel
83 Cyclophosphamide, total body irradiation (TBI) and mabcampath (ALEMTUZUMAB) as conditioning for voluntary unrelated donor (VUD) haemopoietic stem cell transplants (HSCT): the scottish experience Bhandari, S.
 2004
 10 S1 p. 34-35
2 p.
 artikel
84 Cytomegalovirus (CMV) infection in allogeneic non-myeloablative stem cell transplantation recipients Chandrasekar, P.
 2004
 10 S1 p. 43-
1 p.
 artikel
85 Cytomegalovirus (CMV) infection in patients receiving either alemtuzumab (CAMPATH 1-H) or antithymocyte globulin (ATG) as graft-versus-host disease (GVHD) prophylaxis prior to allogeneic stem cell transplantation (SCT) Hunt, W.G.
 2004
 10 S1 p. 37-
1 p.
 artikel
86 Defective populations of regulatory T cells correlate with the occurrence of chronic graft versus host disease after allogeneic stem cell transplantation Zorn, E.
 2004
 10 S1 p. 20-
1 p.
 artikel
87 Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) Ho, V.T.
 2004
 10 S1 p. 7-
1 p.
 artikel
88 Detection and viral load monitoring of BK virus in hemorrhagic cystitis complicating bone marrow transplant patients Manna, P.
 2004
 10 S1 p. 87-88
2 p.
 artikel
89 Determinants of antileukemia effects of allogeneic natural killer cells Leung, W.
 2004
 10 S1 p. 49-
1 p.
 artikel
90 Developing an haematology trials database for the Wellington cancer centre Riley, G.
 2004
 10 S1 p. 106-
1 p.
 artikel
91 Developing nursing standards of practice for blood and marrow (BMT) patients through a shared governance council structure in preparation for the foundation for the accreditation of cellular therapies (FACT) inspection Causton, C.A.
 2004
 10 S1 p. 100-
1 p.
 artikel
92 Development of an MHC-peptide array for the detection and isolation of antigen-specific T-cells: applications in bone marrow transplantation for evaluation of T-cell reconstitution, and detection of host reactive and tumor-reactive T-cells Kraft, D.L.
 2004
 10 S1 p. 24-
1 p.
 artikel
93 Development of a standardized performance management system (balanced scorecard) for hematopoietic progenitor cell processing laboratories Whitteker, T.
 2004
 10 S1 p. 107-
1 p.
 artikel
94 Development of a transplant educational program that provides consistant education, is available on-demand, and is easy to update Kruse, S.M.
 2004
 10 S1 p. 95-96
2 p.
 artikel
95 Development of nutrition algorithms for chronic GVHD Bair, J.D.
 2004
 10 S1 p. 52-53
2 p.
 artikel
96 Differential gene expression profiles of the CD4+CD25+ T suppressor (Ts) cell population in human cord blood and adult peripheral blood vs murine spleen cells Chang, C.-C.
 2004
 10 S1 p. 46-
1 p.
 artikel
97 3-dimensional multi-modality non-invasive imaging of the bone marrow engraftment model Doubrovin, M.
 2004
 10 S1 p. 82-
1 p.
 artikel
98 Diminished sickle cell adhesion molecules following bone marrow transplantation (BMT) Baothman, A.A.
 2004
 10 S1 p. 74-75
2 p.
 artikel
99 Dissection of an MHC mismatched allogeneic transplant model during donor CD4+CD25+ T-cell facilitation of hematopoietic progenitors Hanash, A.M.
 2004
 10 S1 p. 10-11
2 p.
 artikel
100 Distinct differences in GVHD effector activity among donor CD8+ populations: engraftment without GVHD using the facilitating cell Kazerounian, S.
 2004
 10 S1 p. 55-56
2 p.
 artikel
101 DMSO removal reduces stem-cell infusion-related toxicity and allows excellent engraftment of cryopreserved unrelated cord blood and autologous stem cells Oliveira, O.M.W.
 2004
 10 S1 p. 66-
1 p.
 artikel
102 Donor leukocyte-production of rantes significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation Hildebrandt, G.C.
 2004
 10 S1 p. 18-
1 p.
 artikel
103 Donor T cell-derived TNF alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation Hildebrandt, G.C.
 2004
 10 S1 p. 20-
1 p.
 artikel
104 β7−/− donor T cells cause less graft-versus-host disease while preserving graft-versus-tumor activity Waldman, E.D.
 2004
 10 S1 p. 48-49
2 p.
 artikel
105 Dose-intensification and stem cell transplantation (SCT) for histologically transformed low-grade follicular non-hodgkin lymphoma (NHL): a single center experience Vusirikala, M.
 2004
 10 S1 p. 72-
1 p.
 artikel
106 Early production of donor-derived CD4+ CD25+ regulatory T cells in patients given hematopoietic stem cell transplants Woodliff, J.
 2004
 10 S1 p. 25-
1 p.
 artikel
107 Editorial board 2004
 10 S1 p. A3-
1 p.
 artikel
108 Effective RNA loading of CD34+ derived dendritic cells for adoptive immunotherapy Hsu, A.K.W.
 2004
 10 S1 p. 47-
1 p.
 artikel
109 Effect of comorbidities on allogeneic hematopoietic stem cell transplant outcomes in AML/MDS patients in first complete remission Shahjahan, M.
 2004
 10 S1 p. 12-13
2 p.
 artikel
110 Effect of very high CD34 cell dose on the outcome of allogeneic hla identical related transplants Mathews, V.
 2004
 10 S1 p. 11-
1 p.
 artikel
111 Elevated plasma levels of tacrolimus after concurrent use of tacrolimus and voriconazole in the bone marrow transplant setting Cool, R.M.
 2004
 10 S1 p. 104-
1 p.
 artikel
112 Embryonic stem cells as an alternative donor marrow source: engraftment without GVHD Burt, R.K.
 2004
 10 S1 p. 21-22
2 p.
 artikel
113 Empirical studies on molecular fungal diagnostics Manna, P.
 2004
 10 S1 p. 88-
1 p.
 artikel
114 Engraftment and immunologic recovery in six adult patients treated with buCyT and human umbilical cord stem cell transplantation Janakiraman, N.
 2004
 10 S1 p. 58-
1 p.
 artikel
115 Equivalent peripheral blood progenitor cell collections with delayed G-CSF introduction in a cyclophosphamidecontaining mobilisation schedule Doocey, R.T.
 2004
 10 S1 p. 64-
1 p.
 artikel
116 Evaluating the quality of blood and marrow transplantation (BMT) nursing care with a patient perception instrument La Coste, C.M.
 2004
 10 S1 p. 96-97
2 p.
 artikel
117 Evaluation of bone marrow transplanation and arsenic trioxide in the treatment of AML M3 (an experience in Iran) Ghavamzadeh, A.
 2004
 10 S1 p. 61-
1 p.
 artikel
118 Evaluation of the platelet-specific antibody response in thrombocytopenia following allogeneic hematopoietic stem cell transplantation Yamazaki, R.
 2004
 10 S1 p. 68-69
2 p.
 artikel
119 Even coagulase negative staphylococcus infections following reduced intensity transplantation are associated with increased transplant complications and poorer overall survival Chan, G.W.
 2004
 10 S1 p. 11-
1 p.
 artikel
120 Every-point-interactive, quality-controlled, secure clinical data system in single-staff BMT care Gardner, D.H.
 2004
 10 S1 p. 106-
1 p.
 artikel
121 Examining cytotoxic effects on thymic reconstitution: a model Prockop, S.E.
 2004
 10 S1 p. 58-
1 p.
 artikel
122 Expansion of commmon myeloid progenitors in chronic myelomonocytic leukemia Jamieson, C.H.M.
 2004
 10 S1 p. 82-
1 p.
 artikel
123 Expansion of human umbilical cord blood-derived CD34+stem/progenitor cells to treat myocardial infarction Nagler, A.
 2004
 10 S1 p. 5-6
2 p.
 artikel
124 EX VIVO activated and expanded CD8+ T cells recognize malignant cells through a TCR independent and NKG2D dependent pathway Verneris, M.R.
 2004
 10 S1 p. 19-
1 p.
 artikel
125 Ex vivo expansion of immature and mature T cells derived from umbilical cord blood (UCB) Staba, S.L
 2004
 10 S1 p. 16-
1 p.
 artikel
126 FEF25–75% as a spirometric variable in pulmonary function testing (PFT) is predictive for the diagnosis of obliterative bronchiolitis (OB) following myeloablative allogeneic hematopoietic stem cell transplant (HSCT) Burgos-Fuster, L.M.
 2004
 10 S1 p. 69-
1 p.
 artikel
127 Filgrastim (GCSF) is beneficial after autologous peripheral blood grafts with high CD34+ cell content Boulmay, B.
 2004
 10 S1 p. 63-
1 p.
 artikel
128 Fludarabin and busulfan as a conditioning regimen for allogeneic peripheral blood stem cells transplantation in leukemic patients Ghavamzadeh, A.
 2004
 10 S1 p. 35-
1 p.
 artikel
129 Fludarabine based conditioning regimen for allogeneic stem cell transplantation for multiply transfused patients with Fanconi’s anemia George, B.
 2004
 10 S1 p. 33-
1 p.
 artikel
130 Freelite™; a new laboratory tool to aide in monitoring multiple myeloma after treatment Staggs, B.
 2004
 10 S1 p. 71-
1 p.
 artikel
131 Frequency and magnitude of dose adjustment of IV busulfan in targeted dosing strategy for pediatric allogeneic transplantation Grimley, M.S.
 2004
 10 S1 p. 78-
1 p.
 artikel
132 Gastrointestinal graft-versus-host disease after autologous stem cell transplant: incidence, outcome, and risk factors Holmberg, L.A.
 2004
 10 S1 p. 15-
1 p.
 artikel
133 Graft-versus-lymphoma effect yields high percentage of durable complete remission in high-risk patients following mini-transplantation with map (Mitoxantrone, Ara-C, and Pentostatin) regimen Liu, D.
 2004
 10 S1 p. 35-
1 p.
 artikel
134 Haploidentical transplants from positively selected bone marrow haematopoietic stem cells: report of 20 cases Lanfranchi, A.
 2004
 10 S1 p. 42-
1 p.
 artikel
135 Health-related quality of life and symptom distress in patients prior to allogeneic stem cell transplant Bevans, M.
 2004
 10 S1 p. 101-
1 p.
 artikel
136 Health-related quality of life and symptom distress in patients undergoing non-myeloablative (NST) versus myeloablative (MT) allogeneic peripheral blood stem cell transplantation (PBSCT) Bevans, M.
 2004
 10 S1 p. 97-
1 p.
 artikel
137 Hematopoietic stem cell (HSC) redistribution for cardiac repair following acute myocardial infarction (AMI) Atkins, H.
 2004
 10 S1 p. 81-
1 p.
 artikel
138 Hematopoietic stem cell transplantation for the treatment of fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors Boulad, F.
 2004
 10 S1 p. 39-40
2 p.
 artikel
139 High-dose CEB versus beam with autologous stem cell transplant in lymphoma Carrier, E.
 2004
 10 S1 p. 64-
1 p.
 artikel
140 High dose sequential (HDS) followed by autologous bone marrow transplantation (ABMT) as salvage treatment in advanced Hodgkin’s disease (HD) Delamain, M.T.
 2004
 10 S1 p. 65-
1 p.
 artikel
141 HLA-matched related (MRD) or unrelated donor (URD) nonmyeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD) Burroughs, L.M.
 2004
 10 S1 p. 73-74
2 p.
 artikel
142 Human bone marrow-derived CD133+ cells can be expanded ex-vivo in the presence of a polyamine copper chelator Grynspan, F.
 2004
 10 S1 p. 83-
1 p.
 artikel
143 IL-15 as a potential regulator of peripheral NK and CD8+ T cell homeostasis Carson, J.M.
 2004
 10 S1 p. 59-
1 p.
 artikel
144 IL-7 is necessary for the development of experimental graft-versus-host disease (GVHD) Chung, B.
 2004
 10 S1 p. 52-
1 p.
 artikel
145 Immune events following immunoablative therapy for the treatment of multiple sclerosis (MS) Atkins, H.
 2004
 10 S1 p. 62-
1 p.
 artikel
146 Immune reconstitution after allogeneic bone marrow transplantation involves peripheral T cell apoptosis Alpdogan, O.
 2004
 10 S1 p. 58-59
2 p.
 artikel
147 Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after allogeneic bone marrow transplantation Voltarelli, J.
 2004
 10 S1 p. 53-54
2 p.
 artikel
148 Immunosuppression with ATG F allows for successful transplantation from mismatched unrelated donors Zander, A.R.
 2004
 10 S1 p. 33-
1 p.
 artikel
149 Impact of age on outcome of autologous stem cell transplant for follicular and diffuse large B cell lymphoma Arora, A.
 2004
 10 S1 p. 65-
1 p.
 artikel
150 Implementing broviac catheter use in photopheresis for chronic GVHD in pediatric HSCT patients Fisher, V.L.
 2004
 10 S1 p. 101-
1 p.
 artikel
151 Improving clinical and operational outcomes through a shared governance practice council structure Johnston, P.
 2004
 10 S1 p. 94-95
2 p.
 artikel
152 Improving dosing precision in busulfan (bu)-based preparative regimens for hematopoietic stem cell transplantation (HSCT) using parmacokinetics directed therapy (PKDT) Nance, A.G.
 2004
 10 S1 p. 44-45
2 p.
 artikel
153 Indium-111 labelled donor lymphocyte infusion via hepatic artery or I.V. against liver metastases of renal and colon carcinoma after allogeneic haematopoietic stem cell transplantation Barkholt, L.
 2004
 10 S1 p. 80-
1 p.
 artikel
154 Ineffective erythropoiesis in recipient precursor cells following non-myeloablative stem cell transplantation in patients with severe sickle cell anemia Wu, C.J.
 2004
 10 S1 p. 41-
1 p.
 artikel
155 Inhaled cyclosporine: a safe and effective aerosol therapy for chronic graft versus host disease involving lung Anderson, P.M.
 2004
 10 S1 p. 45-46
2 p.
 artikel
156 Interaction between donor type and CMV serostatus on mortality after allogeneic HSCT: do preemptive approaches work equally for all? Nichols, W.G
 2004
 10 S1 p. 84-85
2 p.
 artikel
157 Intravenous busulfan versus melphalan-based low intensity conditioning prior to allogeneic stem-cell transplantation: lower TRM and a more favorable toxicity profile Shimoni, A.
 2004
 10 S1 p. 34-
1 p.
 artikel
158 Introductory remarks 2004
 10 S1 p. A7-
1 p.
 artikel
159 Isolation and functional inhibitory affects of specific peptides bound to type 2 dendritic cells (DC2) Rosenthal, H.S.
 2004
 10 S1 p. 16-17
2 p.
 artikel
160 Isolation of oligodendrocyte precursors from umbilical cord blood Hall, J.G.
 2004
 10 S1 p. 67-
1 p.
 artikel
161 Large volume leukapheresis for autologous peripheral blood stem cell collection in children weighting less than 25 kg Ginani, V.C.
 2004
 10 S1 p. 78-
1 p.
 artikel
162 Late cerebral graft versus host reaction in a girl bone marrow transplanted because of Hurler (MPS I) disease Kyllerman, M
 2004
 10 S1 p. 80-
1 p.
 artikel
163 Leading leaders at one of the largest transplant programs in the country Adornetto, D.
 2004
 10 S1 p. 98-99
2 p.
 artikel
164 Lessons from a positive randomized trial of high-dose chemotherapy in metastatic breast cancer: learn from our mistakes, build on our successes, drain the bathwater, hold the baby Crown, J.P.
 2004
 10 S1 p. 29-
1 p.
 artikel
165 Long-term, apheresis/hemodialysis catheters decrease the incidence of catheter-related blood stream infections (CR-BSI) and venous thrombosis (VT) in patients with al amyloidosis (ALA) undergoing high-dose melphalan and autologous stem cell transplant (AuSCT) Finn, K.
 2004
 10 S1 p. 85-86
2 p.
 artikel
166 Long term disease free survival in patients with mantle cell lymphoma following hematopoietic stem cell transplantation Ganti, A.K.
 2004
 10 S1 p. 27-
1 p.
 artikel
167 Long-term follow up after non-myeloablative allogeneic stem cell transplantation for renal cell carcinoma: the university of Chicago experience Artz, A.S.
 2004
 10 S1 p. 10-
1 p.
 artikel
168 Long term outcome following autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma Deshpande, A.T.
 2004
 10 S1 p. 28-
1 p.
 artikel
169 Low circulating dendritic cell count after allogeneic stem cell transplantation (SCT) predicts death, relapse, and acute graft-versus-host disease (AGVHD) Reddy, V.
 2004
 10 S1 p. 25-
1 p.
 artikel
170 Low dose total body irradiation, fludarabine and antithymocyte globulin conditioning for multiple myeloma (MM) Grosskreutz, C.L.
 2004
 10 S1 p. 44-
1 p.
 artikel
171 Lower post-transplant serum albumin levels predict significantly poorer survival after allogeneic hematopoietic stem cell transplantation Pedicano, J
 2004
 10 S1 p. 84-
1 p.
 artikel
172 Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukaemia: influence of the dose and the source of stem cells; better outcome with rich marrow. On behalf of the acute leukaemia working party (ALWP) of the european cooperative group for blood and marrow transplantation (EBMT) Gorin, N.C.
 2004
 10 S1 p. 9-10
2 p.
 artikel
173 Masthead 2004
 10 S1 p. A2-
1 p.
 artikel
174 Matched and mismatched unrelated cord blood (UCB) stem cell transplant (SCT) in adults: preliminary results of an ongoing prospective trial Chen, W.
 2004
 10 S1 p. 37-
1 p.
 artikel
175 Modulation of Treg cells by extracorporeal photopheresis in chronic graft-vs-host disease Xie, M.
 2004
 10 S1 p. 19-20
2 p.
 artikel
176 Multidisciplinary approach to development of a GVHD outpatient clinic Yount, P.
 2004
 10 S1 p. 52-
1 p.
 artikel
177 Multidisciplinary clinical initiatives to decrease the risk of ethical dilemmas Neumann, J.L.
 2004
 10 S1 p. 97-
1 p.
 artikel
178 Myeloablative related-donor allogeneic stem cell transplants (AlloMSCT) are feasible and can be performed safely in the totally outpatient ambulatory setting Mandanas, R.A.
 2004
 10 S1 p. 40-
1 p.
 artikel
179 Nausea and vomiting in patients receiving high dose chemotherapy followed by peripheral blood stem cell transplant in an outpatient setting Paivanas, N.
 2004
 10 S1 p. 90-91
2 p.
 artikel
180 Neuroleptic malignant syndrome following stem cell transplantation Craig, M.
 2004
 10 S1 p. 89-
1 p.
 artikel
181 Neutropenia and thrombocytopenia induced by G-CSF administration in healthy PBSC allogeneic donors: how long should be prolonged hematological and clinical surveillance? Tassi, C.
 2004
 10 S1 p. 14-
1 p.
 artikel
182 No advantage for more than 4 cycles of VAD prior to autologous stem cell transplantation for multiple myeloma Rodriguez, C.P.
 2004
 10 S1 p. 72-73
2 p.
 artikel
183 Non-GVHD-inducing CD62L− memory T cells promote new T cell regeneration from hematopoietic stem cells Chen, B.J.
 2004
 10 S1 p. 23-
1 p.
 artikel
184 Non-melphalan based conditioning regimens for tandem autografts in multiple myeloma patients Moreb, J.S.
 2004
 10 S1 p. 63-
1 p.
 artikel
185 Non-myeloablative allogeneic hematopoietic stem cell transplantation with pre-transplant immune depletion results in rapid full donor engraftment in pediatric patients with malignancy Fry, T.J.
 2004
 10 S1 p. 36-37
2 p.
 artikel
186 Nonmyeloablative allogeneic stem cell transplantation (NST) for lymphoid malignancies using pentostatin/low-dose total body irradiation Bociek, G.R.
 2004
 10 S1 p. 27-
1 p.
 artikel
187 Non-myeloablative stem cell transplantation in newly established donor stromal microenvironment for facilitation of hematopoietic reconstitution Slavin, S.
 2004
 10 S1 p. 67-
1 p.
 artikel
188 Non-myeloablative stem cell transplant patient education Johns, A.A.
 2004
 10 S1 p. 100-101
2 p.
 artikel
189 Nonmyeloablative transplant in childhood diseases Chik, K.W.
 2004
 10 S1 p. 76-77
2 p.
 artikel
190 Nursing management of patient with hemorrhagic cystitis post BMT Dela Cruz, B.P.
 2004
 10 S1 p. 95-
1 p.
 artikel
191 Officers, directors & board committee chairs 2004 2004
 10 S1 p. A4-
1 p.
 artikel
192 Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation Mates, M.
 2004
 10 S1 p. 36-
1 p.
 artikel
193 One hundred children undergoing allogeneic bone marrow transplantation with cyclopsporin (Neoral) by mouth Mazzolari, E.
 2004
 10 S1 p. 42-
1 p.
 artikel
194 One-year followup: peripheral CD34 counts to guide leukapheresis in peripheral hematopoietic stem cell transplantation Griffin, D.L.
 2004
 10 S1 p. 66-
1 p.
 artikel
195 One year results from the development and utilization of a unified strategic business plan for marketing blood and marrow transplant services’ outpatient clinic Mebane, J.J
 2004
 10 S1 p. 107-
1 p.
 artikel
196 Open-label, randomized comparison of dolasetron versus ondansetron for prevention of nausea and vomiting during high-dose chemotherapy and stem cell transplantation Mandanas, R.A.
 2004
 10 S1 p. 87-
1 p.
 artikel
197 Optimization of chemo-mobilization of autologous blood hematopoietic progenitor cell grafts Hicks, M.L.
 2004
 10 S1 p. 64-65
2 p.
 artikel
198 Optimization of ex-vivo expansion conditions with different growth factor combinations and concentrations maintaining long-term engrafting ability of umbilical cord blood CD34+ stem cells Zhang, J.
 2004
 10 S1 p. 80-81
2 p.
 artikel
199 Optimizing results of non-myeloablative allogeneic transplantation (NMAT): identification of patients at high risk of treatment failure based upon pre-transplant variables Verma, A.
 2004
 10 S1 p. 32-
1 p.
 artikel
200 Oral cryotherapy for prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients Aisa, Y.
 2004
 10 S1 p. 92-
1 p.
 artikel
201 Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation Ayala, E.
 2004
 10 S1 p. 31-
1 p.
 artikel
202 Outcome of transplantation with unrelated donor bone marrow in children with severe thalassemia Pakakasama, S.
 2004
 10 S1 p. 76-
1 p.
 artikel
203 Overlapping immune responses in donor lymphocyte infusion (DLI)-associated graft-vs-host disease Hess, A.D.
 2004
 10 S1 p. 54-
1 p.
 artikel
204 Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial Bensinger, W.
 2004
 10 S1 p. 31-
1 p.
 artikel
205 Partial T cell depletion for unrelated donor BMT for children with severe aplastic anemia (SAA): engraftment with minimal GVHD Bunin, N.
 2004
 10 S1 p. 43-
1 p.
 artikel
206 Patient satisfaction: decreasing the patient “wait time” in the ambulatory care setting Savoie, J.
 2004
 10 S1 p. 99-100
2 p.
 artikel
207 Patients with severe aplastic anemia can be allografted succesfully without anti-thymocyte globulin, using a non-myeloablative conditioning regimen Gómez-Almaguer, D.
 2004
 10 S1 p. 33-
1 p.
 artikel
208 Pediatric patients benefit from intravenous busulfan for myeloablation in allogeneic HSCT Fisher, V.L.
 2004
 10 S1 p. 90-
1 p.
 artikel
209 Pegfilgrastim (neulasta™) following chemotherapy leads to successful mobilization of hematopoietic progenitor cells among transplant patients with various diagnoses Mandanas, R.A.
 2004
 10 S1 p. 14-
1 p.
 artikel
210 Pegylated filgrastim (PF) after high dose chemotherapy (HDC) and autologous stem cell transplant (ASCT) Jagasia, M.H.
 2004
 10 S1 p. 64-
1 p.
 artikel
211 Pentostatin and cyclosporine, a new regimen for the prevention of acute graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation Schwartz, J.E.
 2004
 10 S1 p. 50-
1 p.
 artikel
212 Perforin, FasL, TNFR1, TWEAK, TRAIL, and DR3-TL1a are not required for efficient T cell mediated resistance against allogeneic bone marrow grafts Zimmerman, Z.F.
 2004
 10 S1 p. 39-
1 p.
 artikel
213 Peripheral blood stem cell transplant (PBSCT) in a large series of patients with poems syndrome Dispenzieri, A.
 2004
 10 S1 p. 14-15
2 p.
 artikel
214 Persistently low serum osteoprotegrin levels during the treatment of multiple myeloma patients predicts worse event-free survival Moreb, J.S.
 2004
 10 S1 p. 70-
1 p.
 artikel
215 Pilot study of oral dolasetron and dexamethasone for the control of nausea and vomiting associated with high-dose chemotherapy followed by autologous stem cell transplantation Fancher, K.M.
 2004
 10 S1 p. 105-
1 p.
 artikel
216 Post marketing surveillance of voriconazole (VORI) use in hematopoietic stem cell transplant (HSCT) recipients at a single academic institution Leather, H.L.
 2004
 10 S1 p. 105-
1 p.
 artikel
217 Pre-apheresis therapies affecting CD34+ apheresis yield in multiple myeloma patients Malone, C.
 2004
 10 S1 p. 73-
1 p.
 artikel
218 Prevention of cytomegalovirus (CMV) reactivation by standard dose valacyclovir (VACV) after allogeneic bone marrow transplantation Mori, T.
 2004
 10 S1 p. 30-
1 p.
 artikel
219 Prognostic factors in myelodysplastic syndromes following myeloablative allogenic bone marrow transplantation-a twelve year follow up study Lamba, R.
 2004
 10 S1 p. 37-38
2 p.
 artikel
220 Prospective study of major salivary glands in patients submitted to bone marrow transplantation-preliminary results Coracin, F.L
 2004
 10 S1 p. 69-70
2 p.
 artikel
221 Proteinuria related to chronic graft-versus-host disease after allogeneic stem cell transplantation Carrasco-Yalán, A.A.
 2004
 10 S1 p. 49-
1 p.
 artikel
222 Psychosocial predictors of autologous bone marrow transplant patients’ functioning: indications for early intervention Lanza Hurley, C.
 2004
 10 S1 p. 69-
1 p.
 artikel
223 Rapamycin-generated CD4+, Th2 cells modulate graft-versus-host reaction via an IL-4 dependent mechanism Foley, J
 2004
 10 S1 p. 47-
1 p.
 artikel
224 Rapid conversion to full chimerism after reduced intensity conditioning (RIC) and transplantation of T-cell depleted large numbers of CD34+ stem and CD56+ natural killer (NK) cells obtained from mobilized haploidentical donors Benaim, E.
 2004
 10 S1 p. 56-
1 p.
 artikel
225 Reduced intensity conditioning and allogeneic stem cell transplantation (RIAlloSCT) from unrelated cord blood and matched family donors in children and adolescent recipients results in sustained donor chimerism Del Toro, G.
 2004
 10 S1 p. 76-
1 p.
 artikel
226 Reduced-intensity conditioning (RIC) regimens result in low prevalence of premature ovarian failure (POF) in women underwent hematopoietic stem-cell transplantation (HST) Cheng, Y.C.
 2004
 10 S1 p. 25-26
2 p.
 artikel
227 Reduced intensity peripheral blood stem cell transplant from matched related and unrelated donors for poor risk hematological malignancy Rossetti, J.M.
 2004
 10 S1 p. 34-
1 p.
 artikel
228 Reduced intensity (RI) conditioning and allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with non-malignant disorders Jacobsohn, D.A.
 2004
 10 S1 p. 75-
1 p.
 artikel
229 Reducing pretransplant campath-1H dose does not prevent early CMV reactivation post allogeneic stem cell transplantation Schunn, G.
 2004
 10 S1 p. 59-60
2 p.
 artikel
230 Re-evaluating a patient safety program in an oncology nursing setting Marzan, A.B.
 2004
 10 S1 p. 98-
1 p.
 artikel
231 Results of once daily parenteral busulfan (busulfex®) with cyclophosphamide versus intermittent dosing of busulfan with cyclophosphamide as a preparative regimen for allogeneic transplant recipients with underlying hematological malignancies and diseases Mamlouk, K.
 2004
 10 S1 p. 104-
1 p.
 artikel
232 Results of the cord blood transplantation study (COBLT) unrelated donor banking program Kurtzberg, J.
 2004
 10 S1 p. 21-
1 p.
 artikel
233 Retrospective review of therapy with reduced dose rasburicase in adults with hyperuricemia associated with malignancy Hutcherson, D.A.
 2004
 10 S1 p. 104-
1 p.
 artikel
234 Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients Diaz, M.A.
 2004
 10 S1 p. 45-
1 p.
 artikel
235 Risk factors for syngeneic graft-versus-host disease in adult hematopoietic stem cell transplants Adams, K.M.
 2004
 10 S1 p. 53-
1 p.
 artikel
236 Risk factors of developing acute graft-versus-host disease (AGVHD) after HLA-matched unrelated donor (MUD) transplantation -importance of maintaining the blood level of tacrolimus early after transplantation Okamoto, S.
 2004
 10 S1 p. 47-48
2 p.
 artikel
237 Risk-factors of melphalan/fludarabine dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma Kroger, N.
 2004
 10 S1 p. 74-
1 p.
 artikel
238 RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy Turtle, C.J.
 2004
 10 S1 p. 71-
1 p.
 artikel
239 Role of low-dose heparin, ursodiol and glutamine in preventing veno-occlussive disease of the liver in adults undergoing hematopoietic stem cell transplantation Desai, M.R.
 2004
 10 S1 p. 86-
1 p.
 artikel
240 Role of music therapy-based relaxation vs. expressive reading interventions in blood marrow stem cell transplantation Liesveld, J.L.
 2004
 10 S1 p. 87-
1 p.
 artikel
241 Safety and tolerability of combination anidulafungin (ANID) and liposomal amphotericn B (LAmB) for the treatment of invasive aspergillosis (IA) Herbrecht, R.
 2004
 10 S1 p. 91-
1 p.
 artikel
242 Second hematopoietic stem cell transplant using unrelated donor umbilical cord blood cures 50% of pediatric patients with leukemia relapsing after prior allogeneic transplant from a matched related sibling Staba, S.L
 2004
 10 S1 p. 38-
1 p.
 artikel
243 Selective depletion of T cell clones responsible for GVHD in a murine model Kappel, B.J.
 2004
 10 S1 p. 20-21
2 p.
 artikel
244 Serious complications following unrelated donor marrow collection: experiences of the national marrow donor program® Confer, D.L.
 2004
 10 S1 p. 13-14
2 p.
 artikel
245 Sex streoid ablation therapy restores thymic function and enhances hemopoiesis and lymphopoiesis following allogeneic and autologous stem cell transplantation Sutherland, J.S.
 2004
 10 S1 p. 60-
1 p.
 artikel
246 Should serum voriconazole (Vori) levels be monitored in allogeneic hematopoietic stem cell transplant (HSCT) recipients? Trifilio, S.
 2004
 10 S1 p. 103-104
2 p.
 artikel
247 Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: should the 5/μL threshold required for apheresis be changed? Gidron, A.
 2004
 10 S1 p. 15-16
2 p.
 artikel
248 Significant decreased lipopolysaccharide (LPS)-activated cytokine/receptor, chemokine, immunoregulatory, transcription, apoptotic, signaling and cell structure gene expression in cord blood (CB) compared to adult peripheral blood (APB) monocytes by oligonucleotide gene expression microarray: insight into differential apb versus CB monocyte structure and function Jiang, H.
 2004
 10 S1 p. 58-
1 p.
 artikel
249 Single institution experience with HHV6 infections in the pediatric HSCT patients Olson, E.A.
 2004
 10 S1 p. 41-
1 p.
 artikel
250 Sirolimus and tacrolimus allow engraftment of haploidentical and other alternative donor stem cells after non-myeloablative conditioning Claxton, D.F.
 2004
 10 S1 p. 38-39
2 p.
 artikel
251 Sirolimus and tacrolimus without methotrexate as graft-vs.-host disease prophylaxis after matched, related peripheral blood stem cell transplantation: low transplant related morbidity and excellent GVHD control Cutler, C.
 2004
 10 S1 p. 9-
1 p.
 artikel
252 Soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation Yanik, G.A.
 2004
 10 S1 p. 89-
1 p.
 artikel
253 Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets Vesole, D
 2004
 10 S1 p. 85-
1 p.
 artikel
254 Stem cell transplantation for fanconi anemia: 20 years of progressive decrease in the dose of cyclophosphamide without irradiation Zanis Neto, J.
 2004
 10 S1 p. 13-
1 p.
 artikel
255 Stem cell transplantation for metachromatic leukodystrophy: a family centered approach Maurice, L.C.
 2004
 10 S1 p. 93-
1 p.
 artikel
256 Stem cell transplantation (SCT) for patients(PTS) with genetic diseases: a call for physicians from developing countries to discuss about strategies to improve diagnosis and early referral to BMT centers Bonfim, C.M.S.
 2004
 10 S1 p. 79-
1 p.
 artikel
257 Suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect by inhibiting histone deacetylation Reddy, P.
 2004
 10 S1 p. 17-
1 p.
 artikel
258 Successful treatment of hepatic veno-occlusive disease(VOD) after allogeneic bone marrow transplantation by early administration of a short course of methylprednisolone AlBeihany, A.M.
 2004
 10 S1 p. 45-
1 p.
 artikel
259 Successful use of oral tacrolimus for GVH prophylaxis during the first 100 days post HSCT Nieder, M.L.
 2004
 10 S1 p. 90-
1 p.
 artikel
260 Suspected catheter related blood stream infection (CRBSI) in hematology stem cell transplant patients: tracking rates and outcomes Haller, S.M.
 2004
 10 S1 p. 100-
1 p.
 artikel
261 Table of contents 2004
 10 S1 p. A5-
1 p.
 artikel
262 Tacrolimus conversion from intravenous (I.V.) to oral (P.O.) in allogeneic stem cell transplantation Zimmerman, R.L.
 2004
 10 S1 p. 89-90
2 p.
 artikel
263 Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: altered MMF pharmacokinetics (pk) associated with acute (A)GVHD Bessmertny, O.
 2004
 10 S1 p. 103-
1 p.
 artikel
264 Tacrolimus in combination with steroids for the treatment of chronic GvHD De Jesus, J.
 2004
 10 S1 p. 49-50
2 p.
 artikel
265 Tandem BMT meetings workshop descriptions Horwitz, Edwin M
 2004
 10 S1 p. 1-4
4 p.
 artikel
266 T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT) Sobecks, R.
 2004
 10 S1 p. 41-42
2 p.
 artikel
267 T cell depleted hosts are uniquely susceptible to tolerance induced by non-professional APCs and mediated by IL-10 producing CD8+ T cells Fry, T.J.
 2004
 10 S1 p. 23-
1 p.
 artikel
268 T cell repertoire complexity is conserved after L-leucyl-L-leucine methyl ester (LLME) treatment of donor lymphocyte infusions Friedman, T.M.
 2004
 10 S1 p. 59-
1 p.
 artikel
269 Teambuilding: complexity and challenge in one of the largest transplant programs in the country Stary, S.J.
 2004
 10 S1 p. 99-
1 p.
 artikel
270 Tempo of neutrophil recovery and the definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantation (HSCT) in patients not receiving growth factors post-transplant Naik, P.
 2004
 10 S1 p. 84-
1 p.
 artikel
271 Temporally discordant graft versus leukemia (GVL) and graft versus host (GVH) responses after donor lymphocyte infusion therapy for relapsed chronic myelogenous leukemia Hari, P.N.
 2004
 10 S1 p. 55-
1 p.
 artikel
272 Ten allele high-resolution DNA typing has a direct impact on the disease free survival (DFS) in pediatric recipients of T-cell depleted (TCD) unrelated donor (URD) hematopoietic stem cell transplant (HCT) Prasad, V.K.
 2004
 10 S1 p. 57-
1 p.
 artikel
273 Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma Grosskreutz, C.L.
 2004
 10 S1 p. 73-
1 p.
 artikel
274 The absence of Peyer’s patches or host TNF-A does not affect GVHD progression in an allogeneic BMT model using extensive conditioning regimens Welniak, L.A.
 2004
 10 S1 p. 52-
1 p.
 artikel
275 The addition of interleukin (IL) -18 to anti-CD3, IL-2 and IL-12 for expansion and activation of umbilical cord blood (UCB) cytotoxic T-lymphocytes Satwani, P.
 2004
 10 S1 p. 46-
1 p.
 artikel
276 The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI) Nademanee, A.
 2004
 10 S1 p. 28-
1 p.
 artikel
277 The development of a need assessment tool for families of BMT patients Lee, Y.-S.
 2004
 10 S1 p. 93-
1 p.
 artikel
278 The Duke pediatric stem cell transplant safety program: an initiative to reduce risk and improve patient outcomes Frey, M.A.
 2004
 10 S1 p. 102-
1 p.
 artikel
279 The gift of life comes with a price: the impact of hematopoietic cell transplant on the long-term quality of life of survivors and their spouses Bishop, M.M.
 2004
 10 S1 p. 7-8
2 p.
 artikel
280 The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis of host, graft, and day +50 immune profile Szabolcs, P.
 2004
 10 S1 p. 24-
1 p.
 artikel
281 The impact of pre-transplant anemia on long-term survival following allogeneic bone marrow transplantation Xenocostas, A.
 2004
 10 S1 p. 44-
1 p.
 artikel
282 The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) activation on alloreactive CD4 and CD8 T cells and the development of GVHD Muriglan, S.J.
 2004
 10 S1 p. 5-
1 p.
 artikel
283 Therapeutic antibody mediated depletion of activated dendritic cells and the prevention of graft versus host disease Wilson, J.
 2004
 10 S1 p. 48-
1 p.
 artikel
284 Therapeutic cyclosporine (CSA) monitoring after allogeneic hematopoietic stem cell transplantation (HSCT): high-performance liquid chromatography (HPLC) or TDX? Trifilio, S.
 2004
 10 S1 p. 103-
1 p.
 artikel
285 Therapeutic milestone of donor lymphocyte infusion Austria, M.L.R.
 2004
 10 S1 p. 95-
1 p.
 artikel
286 Therapy for refractory acute graft versus host disease (aGVHD) with basiliximab (BaMab) - a selective interleukin-2 receptor (IL-2R) antagonist Moreira, V.A.
 2004
 10 S1 p. 21-
1 p.
 artikel
287 The role of peyer’s patches and mesenteric lymph nodes in acute GVHD: a study guided by bioluminescence imaging in vivo Beilhack, A.
 2004
 10 S1 p. 5-
1 p.
 artikel
288 The use of fludarabine based reduced intensity conditioning for the treatment of patients with Fanconi’s anemia Slavin, S.
 2004
 10 S1 p. 75-
1 p.
 artikel
289 Thrombotic microangiopathy (TMA) following allogeneic stem-cell transplantation (SCT) in the era of reduced-intensity conditioning: the incidence is not reduced Shimoni, A.
 2004
 10 S1 p. 68-
1 p.
 artikel
290 TID compared to BID mycophenolate mofetil (MMF) improves donor chimerism and engraftment rates without increasing postgrafting toxicities after unrelated peripheral blood stem cell (PBSC) transplantation (HCT) with nonmyeloablative conditioning Maris, M.B.
 2004
 10 S1 p. 35-36
2 p.
 artikel
291 To bleed or not to bleed? that is the question (nursing management of patient with hemorrhagic cystitis post BMT) Dela Cruz, B.P.
 2004
 10 S1 p. 93-
1 p.
 artikel
292 Transient human megakaryopoiesis and platelet production following umbilical cord blood transplantation into NOD/scid mice Cogle, C.R.
 2004
 10 S1 p. 83-
1 p.
 artikel
293 Transplantation of boys with X-linked adrenoleukodystrophy with unrelated-donor, partially HLA-mismatched banked umbilical cord blood Allison, J.
 2004
 10 S1 p. 74-
1 p.
 artikel
294 Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD) Sorror, M.L.
 2004
 10 S1 p. 26-
1 p.
 artikel
295 Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death Ringdén, O.
 2004
 10 S1 p. 17-
1 p.
 artikel
296 Twice daily cefepime for febrile neutropenia following autologous stem cell transplantation Gunderson, H.D
 2004
 10 S1 p. 105-
1 p.
 artikel
297 Umbilical cord blood cells engraft and differentiate in cardiac tissues after human tranplantation Crapnell, K.B.
 2004
 10 S1 p. 83-84
2 p.
 artikel
298 Unique anti-emetic management in the pediatric bone marrow transplant patients Smith, A.
 2004
 10 S1 p. 97-98
2 p.
 artikel
299 Unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with poor risk, relapsed or refractory multiple myeloma Georges, G.E.
 2004
 10 S1 p. 72-
1 p.
 artikel
300 Unrelated donor stem cell transplantation does not result in long term remission in patients with multiple myeloma despite the presence of chronic GVHD Reynolds, C.M.
 2004
 10 S1 p. 51-
1 p.
 artikel
301 Unrelated umbilical cord blood transplantation for familial erythrophagocytic lymphohistiocytosis Archambault, B.L.
 2004
 10 S1 p. 79-80
2 p.
 artikel
302 Unrestricted CTL recognition of HFE, an empty-peptide-groove MHC class I molecule controlling iron metabolism highlights its potential role as a major histocompatibility antigen in unrelated bone marrow tranplantation Rohrlich, P.S.
 2004
 10 S1 p. 51-52
2 p.
 artikel
303 Video visualization of the small bowel aids in the evaluation of intestinal graft versus host disease (GvHD) Morris, J.D.
 2004
 10 S1 p. 88-89
2 p.
 artikel
304 We are kinder to our patients than we are to each other: how can we act the same toward everyone? Sorensen, S.H.
 2004
 10 S1 p. 94-
1 p.
 artikel
305 Zevalin dose-escalation followed by high-dose beam and autotransplant in cd20+ relapsed or refractory non-hodgkin lymphoma (NHL) Winter, J.N.
 2004
 10 S1 p. 28-29
2 p.
 artikel
                             305 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland